| Year |
Citation |
Score |
| 2023 |
Appin CL, Hong C, Suwala AK, Hilz S, Mathur R, Solomon DA, Smirnov IV, Stevers NO, Shai A, Wang A, Berger MS, Chang SM, Phillips JJ, Costello JF. Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression. Neuro-Oncology. PMID 38141254 DOI: 10.1093/neuonc/noad231 |
0.32 |
|
| 2023 |
Kwok DW, Stevers NO, Nejo T, Chen LH, Etxeberria I, Jung J, Okada K, Cove MC, Lakshmanachetty S, Gallus M, Barpanda A, Hong C, Chan GKL, Wu SH, Ramos E, ... ... Phillips JJ, et al. Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens. Biorxiv : the Preprint Server For Biology. PMID 37904942 DOI: 10.1101/2023.10.19.563178 |
0.304 |
|
| 2023 |
Schupp PG, Shelton SJ, Brody DJ, Eliscu R, Johnson BE, Mazor T, Kelley KW, Potts MB, McDermott MW, Huang EJ, Lim DA, Pieper RO, Berger MS, Costello JF, Phillips JJ, et al. Deconstructing Intratumoral Heterogeneity through Multiomic and Multiscale Analysis of Serial Sections. Biorxiv : the Preprint Server For Biology. PMID 37645893 DOI: 10.1101/2023.06.21.545365 |
0.316 |
|
| 2022 |
Lucas CG, Sloan EA, Gupta R, Wu J, Pratt D, Vasudevan HN, Ravindranathan A, Barreto J, Williams EA, Shai A, Whipple NS, Bruggers CS, Maher O, Nabors B, Rodriguez M, ... ... Phillips JJ, et al. Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. Acta Neuropathologica. PMID 35945463 DOI: 10.1007/s00401-022-02478-5 |
0.314 |
|
| 2021 |
Babikir H, Wang L, Shamardani K, Catalan F, Sudhir S, Aghi MK, Raleigh DR, Phillips JJ, Diaz AA. ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma. Genome Biology. 22: 311. PMID 34763709 DOI: 10.1186/s13059-021-02535-4 |
0.312 |
|
| 2020 |
Jones LE, Hilz S, Grimmer MR, Mazor T, Najac C, Mukherjee J, McKinney A, Chow T, Pieper RO, Ronen SM, Chang SM, Phillips JJ, Costello JF. Patient-derived cells from recurrent tumors that model the evolution of -mutant glioma. Neuro-Oncology Advances. 2: vdaa088. PMID 32904945 DOI: 10.1093/noajnl/vdaa088 |
0.31 |
|
| 2020 |
Lucas CG, Gupta R, Doo P, Lee JC, Cadwell CR, Ramani B, Hofmann JW, Sloan EA, Kleinschmidt-DeMasters BK, Lee HS, Wood MD, Grafe M, Born D, Vogel H, Salamat S, ... ... Phillips JJ, et al. Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor. Acta Neuropathologica Communications. 8: 151. PMID 32859279 DOI: 10.1186/S40478-020-01027-Z |
0.397 |
|
| 2020 |
Blomquist MR, Ensign SF, D'Angelo F, Phillips JJ, Ceccarelli M, Peng S, Halperin RF, Caruso FP, Garofano L, Byron SA, Liang WS, Craig DW, Carpten JD, Prados MD, Trent JM, et al. Temporospatial genomic profiling in glioblastoma identifies commonly altered core pathways underlying tumor progression. Neuro-Oncology Advances. 2: vdaa078. PMID 32743548 DOI: 10.1093/noajnl/vdaa078 |
0.306 |
|
| 2020 |
Cluceru J, Nelson SJ, Wen Q, Phillips JJ, Shai A, Molinaro AM, Alcaide-Leon P, Olson MP, Nair D, LaFontaine M, Chunduru P, Villanueva-Meyer JE, Cha S, Chang SM, Berger MS, et al. Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomas. Neuro-Oncology. PMID 32319527 DOI: 10.1093/Neuonc/Noaa094 |
0.359 |
|
| 2020 |
Mondal G, Lee JC, Ravindranathan A, Villanueva-Meyer JE, Tran QT, Allen SJ, Barreto J, Gupta R, Doo P, Van Ziffle J, Onodera C, Devine P, Grenert JP, Samuel D, Li R, ... ... Phillips JJ, et al. Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition. Acta Neuropathologica. PMID 32303840 DOI: 10.1007/S00401-020-02155-5 |
0.382 |
|
| 2020 |
Mathur R, Zhang Y, Grimmer MR, Hong C, Zhang M, Bollam S, Petrecca K, Clarke J, Berger MS, Phillips JJ, Oberheim-Bush NA, Molinaro AM, Chang SM, Costello JF. MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence. Neuro-Oncology. PMID 32166314 DOI: 10.1093/Neuonc/Noaa059 |
0.367 |
|
| 2020 |
Molinaro AM, Hervey-Jumper S, Morshed RA, Young J, Han SJ, Chunduru P, Zhang Y, Phillips JJ, Shai A, Lafontaine M, Crane J, Chandra A, Flanigan P, Jahangiri A, Cioffi G, et al. Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma. Jama Oncology. PMID 32027343 DOI: 10.1001/Jamaoncol.2019.6143 |
0.379 |
|
| 2020 |
Oberheim Bush NA, Yu Y, Villanueva-Meyer J, Grimmer M, Hilz S, Solomon D, Choi S, Mazor T, Hong C, Shai A, Phillips JJ, McDermott M, Haas-Kogan DA, Taylor J, Butowski NA, et al. Temozolomide-induced hypermutation is associated with high-grade transformation, distant recurrence, and reduced survival after transformation in initially low-grade IDH-mutant diffuse gliomas. Journal of Clinical Oncology. 38: 2506-2506. DOI: 10.1200/Jco.2020.38.15_Suppl.2506 |
0.366 |
|
| 2019 |
Berens ME, Sood A, Barnholtz-Sloan JS, Graf JF, Cho S, Kim S, Kiefer J, Byron SA, Halperin RF, Nasser S, Adkins J, Cuyugan L, Devine K, Ostrom Q, Couce M, ... ... Phillips JJ, et al. Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas. Plos One. 14: e0219724. PMID 31881020 DOI: 10.1371/Journal.Pone.0219724 |
0.436 |
|
| 2019 |
McKinney A, Lindberg OR, Engler JR, Chen KY, Kumar A, Gong H, Lu KV, Simonds EF, Cloughesy TF, Liau LM, Prados M, Bollen AW, Berger MS, Shieh JTC, James CD, ... ... Phillips JJ, et al. Mechanisms of resistance to EGFR inhibition reveal metabolic vulnerabilities in human GBM. Molecular Cancer Therapeutics. PMID 31270152 DOI: 10.1158/1535-7163.Mct-18-1330 |
0.415 |
|
| 2019 |
Huang M, Tailor J, Zhen Q, Gillmor AH, Miller ML, Weishaupt H, Chen J, Zheng T, Nash EK, McHenry LK, An Z, Ye F, Takashima Y, Clarke J, Ayetey H, ... ... Phillips JJ, et al. Engineering Genetic Predisposition in Human Neuroepithelial Stem Cells Recapitulates Medulloblastoma Tumorigenesis. Cell Stem Cell. PMID 31204176 DOI: 10.1016/J.Stem.2019.05.013 |
0.357 |
|
| 2019 |
Chen H, Thomas C, Munoz FA, Alexandrescu S, Horbinski CM, Olar A, McGuone D, Camelo-Piragua S, Wang L, Pentsova E, Phillips J, Aldape K, Chen W, Iafrate AJ, Chi AS, et al. Polysomy is associated with poor outcome in 1p19q co-deleted oligodendroglial tumors. Neuro-Oncology. PMID 31140557 DOI: 10.1093/Neuonc/Noz098 |
0.373 |
|
| 2019 |
Ferris SP, Velazquez Vega J, Aboian M, Lee JC, Ziffle JV, Onodera C, Grenert JP, Saunders T, Chen YY, Banerjee A, Kline CN, Gupta N, Raffel C, Samuel D, Ruiz-Diaz I, ... ... Phillips JJ, et al. High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication - a comprehensive clinical, radiographic, pathologic, and genomic analysis. Brain Pathology (Zurich, Switzerland). PMID 31104347 DOI: 10.1111/Bpa.12747 |
0.447 |
|
| 2019 |
Widhalm G, Olson J, Weller J, Bravo J, Han SJ, Phillips J, Hervey-Jumper SL, Chang SM, Roberts DW, Berger MS. The value of visible 5-ALA fluorescence and quantitative protoporphyrin IX analysis for improved surgery of suspected low-grade gliomas. Journal of Neurosurgery. 1-10. PMID 31075771 DOI: 10.3171/2019.1.Jns182614 |
0.342 |
|
| 2019 |
Lee JC, Mazor T, Lao R, Wan E, Diallo AB, Hill NS, Thangaraj N, Wendelsdorf K, Samuel D, Kline CN, Banerjee A, Auguste K, Raffel C, Gupta N, Berger M, ... ... Phillips JJ, et al. Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma. Acta Neuropathologica. PMID 30877433 DOI: 10.1007/S00401-019-01990-5 |
0.319 |
|
| 2019 |
Mueller S, Jain P, Liang WS, Kilburn L, Kline C, Gupta N, Panditharatna E, Magge SN, Zhang B, Zhu Y, Crawford JR, Banerjee A, Nazemi K, Packer RJ, Petritsch CK, ... ... Phillips JJ, et al. A pilot precision medicine trial for children with diffuse intrinsic pontine glioma - PNOC003: a report from the Pacific Pediatric Neuro-Oncology Consortium. International Journal of Cancer. PMID 30861105 DOI: 10.1002/Ijc.32258 |
0.391 |
|
| 2019 |
Sabelström H, Quigley D, Fenster T, Foster DJ, Fuchshuber CAM, Saxena S, Yuan E, Li N, Paterno F, Phillips JJ, James CD, Norling B, Berger MS, Persson AI. High density is a property of slow-cycling and treatment-resistant human glioblastoma cells. Experimental Cell Research. PMID 30844389 DOI: 10.1016/J.Yexcr.2019.03.003 |
0.386 |
|
| 2019 |
Calixto-Hope L, Lee J, Sloan E, Hofmann J, Van Ziffle J, Onodera C, Grenert J, Devine P, Kline C, Banerjee A, Clarke J, Taylor J, Ann Oberheim-Bush N, Buerki R, Butowski N, ... ... Phillips J, et al. PATH-38. ROSETTE-FORMING GLIONEURONAL TUMOR IS DEFINED BY FGFR1 ACTIVATING ALTERATIONS WITH FREQUENT ACCOMPANYING PI3K AND MAPK PATHWAY MUTATIONS Neuro-Oncology. 21: vi151-vi152. DOI: 10.1093/Neuonc/Noz175.634 |
0.381 |
|
| 2019 |
Zhang M, Hilz S, Martin M, Hong C, Yu Y, Bollam S, Grimmer M, Looney T, Lowman G, Ganpule G, Phillips J, Shai A, Chang S, Clarke J, Taylor J, et al. IMMU-11. SPATIOTEMPORAL IMMUNOGENOMIC ANALYSIS OF THE T-CELL REPERTOIRE IN IDH-MUTANT LOWER GRADE GLIOMAS Neuro-Oncology. 21: vi121-vi121. DOI: 10.1093/Neuonc/Noz175.505 |
0.367 |
|
| 2019 |
Hilz S, Hong C, Jalbert L, Mazor T, Martin M, Kumar A, Shelton S, Wong K, Hayes J, Yu Y, Zhang M, Luks T, Olson M, Lafontaine M, Shai A, ... ... Phillips J, et al. GENE-47. A 3D ATLAS TO EVALUATE THE SPATIAL PATTERNING OF GENETIC ALTERATIONS AND TUMOR CELL STATES IN GLIOMA Neuro-Oncology. 21: vi107-vi108. DOI: 10.1093/Neuonc/Noz175.449 |
0.425 |
|
| 2019 |
Taylor J, Molinaro A, Rodriguez Almaraz E, Downey C, Phillips J, Ann Oberheim-Bush N, Butowski N, Chang S, Berger M, Prados M, Haas-Kogan D, Clarke J. ACTR-42. PI3K/mTOR PATHWAY ACTIVATION SELECTED PHASE II STUDY OF EVEROLIMUS (RAD001) WITH AND WITHOUT TEMOZOLOMIDE IN THE TREATMENT OF ADULT PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMA [NCT NCT02023905] Neuro-Oncology. 21: vi22-vi23. DOI: 10.1093/Neuonc/Noz175.084 |
0.361 |
|
| 2019 |
Kumar A, Chen K, Patel S, Petritsch C, Nicolaides T, Solomon DA, Phillips JJ. Lgg-10. Tumor-Associated Immune Response In Anaplastic Progression Of Pxa Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz036.153 |
0.344 |
|
| 2018 |
Barnes JM, Kaushik S, Bainer RO, Sa JK, Woods EC, Kai F, Przybyla L, Lee M, Lee HW, Tung JC, Maller O, Barrett AS, Lu KV, Lakins JN, Hansen KC, ... ... Phillips JJ, et al. A tension-mediated glycocalyx-integrin feedback loop promotes mesenchymal-like glioblastoma. Nature Cell Biology. PMID 30202050 DOI: 10.1038/S41556-018-0183-3 |
0.338 |
|
| 2018 |
López GY, Van Ziffle J, Onodera C, Grenert JP, Yeh I, Bastian BC, Clarke J, Oberheim Bush NA, Taylor J, Chang S, Butowski N, Banerjee A, Mueller S, Kline C, Torkildson J, ... ... Phillips JJ, et al. The genetic landscape of gliomas arising after therapeutic radiation. Acta Neuropathologica. PMID 30196423 DOI: 10.1007/S00401-018-1906-Z |
0.426 |
|
| 2018 |
Taylor JW, Parikh M, Phillips JJ, James CD, Molinaro AM, Butowski NA, Clarke JL, Oberheim-Bush NA, Chang SM, Berger MS, Prados M. Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma. Journal of Neuro-Oncology. PMID 30151703 DOI: 10.1007/S11060-018-2977-3 |
0.33 |
|
| 2018 |
Phillips JJ, Gong H, Chen K, Joseph NM, van Ziffle J, Bastian BC, Grenert JP, Kline CN, Mueller S, Banerjee A, Nicolaides T, Gupta N, Berger MS, Lee HS, Pekmezci M, et al. The genetic landscape of anaplastic pleomorphic xanthoastrocytoma. Brain Pathology (Zurich, Switzerland). PMID 30051528 DOI: 10.1111/Bpa.12639 |
0.44 |
|
| 2018 |
Luks TL, McKnight TR, Jalbert LE, Williams A, Neill E, Lobo KA, Persson AI, Perry A, Phillips JJ, Molinaro AM, Chang SM, Nelson SJ. Relationship of In Vivo MR Parameters to Histopathological and Molecular Characteristics of Newly Diagnosed, Nonenhancing Lower-Grade Gliomas. Translational Oncology. 11: 941-949. PMID 29883968 DOI: 10.1016/J.Tranon.2018.05.005 |
0.368 |
|
| 2018 |
Griveau A, Seano G, Shelton SJ, Kupp R, Jahangiri A, Obernier K, Krishnan S, Lindberg OR, Yuen TJ, Tien AC, Sabo JK, Wang N, Chen I, Kloepper J, Larrouquere L, ... ... Phillips JJ, et al. A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment. Cancer Cell. PMID 29681511 DOI: 10.1016/J.Ccell.2018.03.020 |
0.389 |
|
| 2018 |
Viswanath P, Radoul M, Izquierdo-Garcia JL, Luchman HA, Gregory Cairncross J, Pieper RO, Phillips JJ, Ronen SM. Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner. Cancer & Metabolism. 6: 3. PMID 29619216 DOI: 10.1186/S40170-018-0178-3 |
0.317 |
|
| 2018 |
Vasudevan HN, Braunstein SE, Phillips JJ, Pekmezci M, Tomlin BA, Wu A, Reis GF, Magill ST, Zhang J, Feng FY, Nicholaides T, Chang SM, Sneed PK, McDermott MW, Berger MS, et al. Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma Proliferation. Cell Reports. 22: 3672-3683. PMID 29590631 DOI: 10.1016/J.Celrep.2018.03.013 |
0.36 |
|
| 2018 |
Goode B, Mondal G, Hyun M, Ruiz DG, Lin YH, Van Ziffle J, Joseph NM, Onodera C, Talevich E, Grenert JP, Hewedi IH, Snuderl M, Brat DJ, Kleinschmidt-DeMasters BK, Rodriguez FJ, ... ... Phillips JJ, et al. A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle. Nature Communications. 9: 810. PMID 29476136 DOI: 10.1038/S41467-018-02826-8 |
0.439 |
|
| 2018 |
Viswanath P, Radoul M, Izquierdo-Garcia JL, Ong WQ, Luchman HA, Cairncross JG, Huang B, Pieper RO, Phillips JJ, Ronen SM. 2-hydroxyglutarate-mediated autophagy of the endoplasmic reticulum leads to an unusual downregulation of phospholipid biosynthesis in mutant IDH1 gliomas. Cancer Research. PMID 29358170 DOI: 10.1158/0008-5472.Can-17-2926 |
0.36 |
|
| 2018 |
Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, Barthel F, Cho HJ, Lin YH, Satani N, Martinez-Ledesma E, ... ... Phillips JJ, et al. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Cancer Cell. 33: 152. PMID 29316430 DOI: 10.1016/J.Ccell.2017.12.012 |
0.39 |
|
| 2018 |
Peng S, Halperin R, Dhruv H, Byron S, Legendre C, Phillips J, Prados M, Berens M, Tran N. Abstract 289: Probing the non-enhancing component of glioblastoma: Targeting what is left behind Cancer Research. 78: 289-289. DOI: 10.1158/1538-7445.Am2018-289 |
0.407 |
|
| 2018 |
Grossauer S, Koeck K, Chouchane M, Phillips JJ, Petritsch CK, Nicolaides T. Abstract 143: MAPK pathway blockade effects on glioma stem cells and immunotherapy in BRAFV600E mutant gliomas Cancer Research. 78: 143-143. DOI: 10.1158/1538-7445.Am2018-143 |
0.387 |
|
| 2018 |
Cluceru J, Nelson S, Molinaro A, Phillips JJ, Olson B, Lafontaine M, Jakary A, Nair D, Chang S, Alcaide-Leon P, Berger M, Lupo J. NIMG-11. DIFFERENTIATING TREATMENT-INDUCED EFFECTS FROM TRUE RECURRENT HIGH GRADE GLIOMA USING MULTIPARAMETRIC MRI TECHNIQUES Neuro-Oncology. 20: vi177-vi178. DOI: 10.1093/Neuonc/Noy148.738 |
0.306 |
|
| 2017 |
Goode B, Joseph NM, Stevers M, Van Ziffle J, Onodera C, Talevich E, Grenert JP, Yeh I, Bastian BC, Phillips JJ, Garg K, Rabban JT, Zaloudek C, Solomon DA. Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 29148537 DOI: 10.1038/Modpathol.2017.153 |
0.43 |
|
| 2017 |
Hayes J, Yu Y, Jalbert LE, Mazor T, Jones LE, Wood MD, Walsh KM, Bengtsson H, Hong C, Oberndorfer S, Roetzer T, Smirnov IV, Clarke JL, Aghi MK, Chang SM, ... ... Phillips JJ, et al. Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas. Neuro-Oncology. PMID 29077933 DOI: 10.1093/Neuonc/Nox205 |
0.393 |
|
| 2017 |
Autry A, Phillips JJ, Maleschlijski S, Roy R, Molinaro AM, Chang SM, Cha S, Lupo JM, Nelson SJ. Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor. Translational Oncology. 10: 895-903. PMID 28942218 DOI: 10.1016/J.Tranon.2017.08.009 |
0.377 |
|
| 2017 |
Mazor T, Chesnelong C, Pankov A, Jalbert LE, Hong C, Hayes J, Smirnov IV, Marshall R, Souza CF, Shen Y, Viswanath P, Noushmehr H, Ronen SM, Jones SJM, Marra MA, ... ... Phillips JJ, et al. Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1. Proceedings of the National Academy of Sciences of the United States of America. PMID 28916733 DOI: 10.1073/Pnas.1708914114 |
0.4 |
|
| 2017 |
Tran VM, Wade A, McKinney A, Chen K, Lindberg OR, Engler JR, Persson AI, Phillips JJ. Heparan Sulfate Glycosaminoglycans in Glioblastoma Promote Tumor Invasion. Molecular Cancer Research : McR. PMID 28778876 DOI: 10.1158/1541-7786.Mcr-17-0352 |
0.427 |
|
| 2017 |
Wahl M, Chang SM, Phillips JJ, Molinaro AM, Costello JF, Mazor T, Alexandrescu S, Lupo JM, Nelson SJ, Berger M, Prados M, Taylor JW, Butowski N, Clarke JL, Haas-Kogan D. Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas. Cancer. PMID 28759109 DOI: 10.1002/Cncr.30909 |
0.318 |
|
| 2017 |
Chan AK, Han SJ, Choy W, Beleford D, Aghi MK, Berger MS, Shieh JT, Bollen AW, Perry A, Phillips JJ, Butowski N, Solomon DA. Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A/B deletion and a significant family history. Clinical Neuropathology. PMID 28699883 DOI: 10.5414/Np301022 |
0.363 |
|
| 2017 |
Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, Barthel F, Cho HJ, Lin YH, Satani N, Martinez-Ledesma E, ... ... Phillips JJ, et al. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Cancer Cell. 32: 42-56.e6. PMID 28697342 DOI: 10.1016/J.Ccell.2017.06.003 |
0.415 |
|
| 2017 |
Banerjee A, Jakacki RI, Onar-Thomas A, Wu S, Nicolaides T, Young Poussaint T, Fangusaro J, Phillips J, Perry A, Turner D, Prados M, Packer RJ, Qaddoumi I, Gururangan S, Pollack IF, et al. A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study. Neuro-Oncology. PMID 28339824 DOI: 10.1093/Neuonc/Now282 |
0.354 |
|
| 2017 |
Jalbert LE, Elkhaled A, Phillips JJ, Neill E, Williams A, Crane JC, Olson MP, Molinaro AM, Berger MS, Kurhanewicz J, Ronen SM, Chang SM, Nelson SJ. Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating Glioma. Scientific Reports. 7: 44792. PMID 28327577 DOI: 10.1038/Srep44792 |
0.414 |
|
| 2017 |
Fan Q, Aksoy O, Wong RA, Ilkhanizadeh S, Novotny CJ, Gustafson WC, Truong AY, Cayanan G, Simonds EF, Haas-Kogan D, Phillips JJ, Nicolaides T, Okaniwa M, Shokat KM, Weiss WA. A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma. Cancer Cell. 31: 424-435. PMID 28292440 DOI: 10.1016/J.Ccell.2017.01.014 |
0.319 |
|
| 2017 |
Lin CA, Rhodes CT, Lin C, Phillips JJ, Berger MS. Comparative Analyses Identify Molecular Signature of MRI-Classified SVZ-associated Glioblastoma. Cell Cycle (Georgetown, Tex.). 0. PMID 28278055 DOI: 10.1080/15384101.2017.1295186 |
0.38 |
|
| 2017 |
Kuang R, Jahangiri A, Mascharak S, Nguyen A, Chandra A, Flanigan PM, Yagnik G, Wagner JR, De Lay M, Carrera D, Castro BA, Hayes J, Sidorov M, Garcia JL, Eriksson P, ... ... Phillips J, et al. GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance. Jci Insight. 2: e88815. PMID 28138554 DOI: 10.1172/Jci.Insight.88815 |
0.333 |
|
| 2017 |
Neill E, Luks T, Dayal M, Phillips JJ, Perry A, Jalbert LE, Cha S, Molinaro A, Chang SM, Nelson SJ. Quantitative multi-modal MR imaging as a non-invasive prognostic tool for patients with recurrent low-grade glioma. Journal of Neuro-Oncology. PMID 28124178 DOI: 10.1007/S11060-016-2355-Y |
0.342 |
|
| 2017 |
Kaushik S, Phillips JJ, Weaver VM. Abstract 3985: NCoR2 regulates glioblastoma progression and treatment resistance Cancer Research. 77: 3985-3985. DOI: 10.1158/1538-7445.Am2017-3985 |
0.416 |
|
| 2017 |
Batsios G, Viswanath P, Phillips JJ, Pieper RO, Ronen S. EXTH-51. PI3K/mTOR INHIBITION LEADS TO REDUCTION IN 2HG PRODUCTION AND CELL PROLIFERATION IN IDH1 MUTANT CELLS. Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.343 |
0.34 |
|
| 2017 |
Jones L, Mazor T, Grimmer M, Najac C, Mukherjee J, Chow T, Pieper R, Ronen S, Phillips JJ, Chang S, Costello J. TMOD-23. ESTABLISHMENT AND CHARACTERIZATION OF IDH1-MUTANT HYPERMUTATED GLIOMA CELL LINES Neuro-Oncology. 19: vi259-vi259. DOI: 10.1093/Neuonc/Nox168.1060 |
0.311 |
|
| 2017 |
Wang Q, Hu B, Hu X, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, Barthel FP, Cho HJ, Lin Y, Satani N, Martinez-Ledesma E, Zheng S, ... ... Phillips JJ, et al. TMIC-22. DECIPHERING GLIOMA INTRINSIC TRANSCRIPTIONAL SUBTYPES IDENTIFIES TUMOR EVOLUTION ASSOCIATES WITH CHANGES IN IMMUNE-MICROENVIRONMENT Neuro-Oncology. 19: vi247-vi248. DOI: 10.1093/Neuonc/Nox168.1011 |
0.362 |
|
| 2017 |
Taylor JW, Molinaro AM, Phillips JJ, James CD, Butowski NA, Clarke JL, Oberheim Bush N, Chang SM, Berger MS, Prados M. P09.59 Phase 2 trial of palbociclib in adult patients with recurrent Rb positive glioblastoma Neuro-Oncology. 19: iii83-iii83. DOI: 10.1093/Neuonc/Nox036.314 |
0.32 |
|
| 2017 |
Vasudevan H, Braunstein S, Wu A, Reis G, Magill S, Phillips J, Chang S, Sneed P, McDermott M, Perry A, Raleigh D. Molecular Profiling of Meningioma Identifies Genomic Signatures That Predict Clinical Outcomes Independent of Tumor Grade International Journal of Radiation Oncology*Biology*Physics. 99: S22. DOI: 10.1016/J.Ijrobp.2017.06.064 |
0.351 |
|
| 2016 |
Ge X, Gong H, Dumas K, Litwin J, Phillips JJ, Waisfisz Q, Weiss MM, Hendriks Y, Stuurman KE, Nelson SF, Grody WW, Lee H, Kwok PY, Shieh JT. Missense-depleted regions in population exomes implicate ras superfamily nucleotide-binding protein alteration in patients with brain malformation. Npj Genomic Medicine. 1. PMID 28868155 DOI: 10.1038/Npjgenmed.2016.36 |
0.301 |
|
| 2016 |
Torchia J, Golbourn B, Feng S, Ho KC, Sin-Chan P, Vasiljevic A, Norman JD, Guilhamon P, Garzia L, Agamez NR, Lu M, Chan TS, Picard D, de Antonellis P, Khuong-Quang DA, ... ... Phillips J, et al. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors. Cancer Cell. 30: 891-908. PMID 27960086 DOI: 10.1016/J.Ccell.2016.11.003 |
0.387 |
|
| 2016 |
Hu B, Wang Q, Wang YA, Hua S, Sauvé CG, Ong D, Lan ZD, Chang Q, Ho YW, Monasterio MM, Lu X, Zhong Y, Zhang J, Deng P, Tan Z, ... ... Phillips JJ, et al. Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth. Cell. 167: 1281-1295.e18. PMID 27863244 DOI: 10.1016/J.Cell.2016.10.039 |
0.399 |
|
| 2016 |
Miroshnikova YA, Mouw JK, Barnes JM, Pickup MW, Lakins JN, Kim Y, Lobo K, Persson AI, Reis GF, McKnight TR, Holland EC, Phillips JJ, Weaver VM. Tissue mechanics promote IDH1-dependent HIF1α-tenascin C feedback to regulate glioblastoma aggression. Nature Cell Biology. PMID 27820599 DOI: 10.1038/Ncb3429 |
0.381 |
|
| 2016 |
Ohba S, Mukherjee J, Johannessen TC, Mancini A, Chow TT, Wood M, Jones L, Mazor T, Marshall RE, Viswanath P, Walsh KM, Perry A, Bell RJ, Phillips JJ, Costello JF, et al. Mutant IDH1 expression drives TERT promoter reactivation as part of the cellular transformation process. Cancer Research. PMID 27758882 DOI: 10.1158/0008-5472.Can-16-0696 |
0.354 |
|
| 2016 |
Lindberg OR, McKinney A, Engler JR, Koshkakaryan G, Gong H, Robinson AE, Ewald AJ, Huillard E, James CD, Molinaro AM, Shieh JT, Phillips JJ. GBM heterogeneity as a function of variable epidermal growth factor receptor variant III activity. Oncotarget. PMID 27738329 DOI: 10.18632/Oncotarget.12600 |
0.424 |
|
| 2016 |
Grossauer S, Koeck K, Murphy NE, Meyers ID, Daynac M, Truffaux N, Truong AY, Nicolaides TP, McMahon M, Berger MS, Phillips JJ, James CD, Petritsch CK. Concurrent MEK targeted therapy prevents MAPK pathway reactivation during BRAFV600E targeted inhibition in a novel syngeneic murine glioma model. Oncotarget. PMID 27713119 DOI: 10.18632/Oncotarget.12419 |
0.414 |
|
| 2016 |
Lal S, Peng KW, Steele MB, Jenks N, Ma H, Kohanbash G, Phillips JJ, Raffel C. Safety study: Intraventricular injection of a modified oncolytic measles virus into measles-immune, hCD46-transgenic, IFNαRko mice. Human Gene Therapy. Clinical Development. PMID 27604429 DOI: 10.1089/Humc.2016.062 |
0.31 |
|
| 2016 |
Wahl M, Phillips JJ, Molinaro AM, Lin Y, Perry A, Haas-Kogan DA, Costello JF, Dayal M, Butowski N, Clarke JL, Prados M, Nelson S, Berger MS, Chang SM. Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide. Neuro-Oncology. PMID 27571885 DOI: 10.1093/Neuonc/Now176 |
0.35 |
|
| 2016 |
Wood MD, Reis GF, Reuss DE, Phillips JJ. Protein Analysis of Glioblastoma Primary and Posttreatment Pairs Suggests a Mesenchymal Shift at Recurrence. Journal of Neuropathology and Experimental Neurology. PMID 27539476 DOI: 10.1093/Jnen/Nlw068 |
0.442 |
|
| 2016 |
Barajas RF, Butowski NA, Phillips JJ, Aghi MK, Berger MS, Chang SM, Cha S. The Development of Reduced Diffusion Following Bevacizumab Therapy Identifies Regions of Recurrent Disease in Patients with High-grade Glioma. Academic Radiology. PMID 27443507 DOI: 10.1016/J.Acra.2016.04.004 |
0.368 |
|
| 2016 |
Jones C, Karajannis MA, Jones DT, Kieran MW, Monje M, Baker SJ, Becher OJ, Cho YJ, Gupta N, Hawkins C, Hargrave D, Haas-Kogan DA, Jabado N, Li XN, Mueller S, ... ... Phillips JJ, et al. Pediatric high-grade glioma: biologically and clinically in need of new thinking. Neuro-Oncology. PMID 27282398 DOI: 10.1093/Neuonc/Now101 |
0.341 |
|
| 2016 |
Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DT, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I, Ryzhova M, Koelsche C, Pfaff E, Allen SJ, Balasubramanian G, ... ... Phillips JJ, et al. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell. 164: 1060-1072. PMID 26919435 DOI: 10.1016/J.Cell.2016.01.015 |
0.423 |
|
| 2016 |
Jalbert LE, Neill E, Phillips JJ, Lupo JM, Olson MP, Molinaro AM, Berger MS, Chang SM, Nelson SJ. Magnetic resonance analysis of malignant transformation in recurrent glioma. Neuro-Oncology. PMID 26911151 DOI: 10.1093/Neuonc/Now008 |
0.351 |
|
| 2016 |
Radoul M, Chaumeil MM, Eriksson P, Wang AS, Phillips JJ, Ronen SM. MR Studies of Glioblastoma Models Treated with Dual PI3K/mTOR Inhibitor and Temozolomide - Metabolic Changes are Associated with Enhanced Survival. Molecular Cancer Therapeutics. PMID 26883274 DOI: 10.1158/1535-7163.Mct-15-0769 |
0.381 |
|
| 2016 |
Mukherjee J, Ohba S, See WL, Phillips JJ, Molinaro AM, Pieper RO. PKM2 uses control of HuR localization to regulate p27 and cell cycle progression in human glioblastoma cells. International Journal of Cancer. Journal International Du Cancer. PMID 26874904 DOI: 10.1002/Ijc.30041 |
0.328 |
|
| 2016 |
Bandopadhayay P, Ramkissoon LA, Jain P, Bergthold G, Wala J, Zeid R, Schumacher SE, Urbanski L, O'Rourke R, Gibson WJ, Pelton K, Ramkissoon SH, Han HJ, Zhu Y, Choudhari N, ... ... Phillips JJ, et al. MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism. Nature Genetics. PMID 26829751 DOI: 10.1038/Ng.3500 |
0.421 |
|
| 2016 |
Prados M, Kuhn JG, Colman H, Cloughesy TF, Chang SM, Butowski NA, De Groot JF, Wen PY, Ligon KL, Mellinghoff IK, Chi AS, Phillips JJ, Molinaro AM, Halperin R, Tran N, et al. Precision medicine in recurrent glioblastoma: A feasibility trial conducted by the Ivy Foundation Early Phase Clinical Trials Consortium. Journal of Clinical Oncology. 34: 2031-2031. DOI: 10.1200/Jco.2016.34.15_Suppl.2031 |
0.392 |
|
| 2016 |
Wahl MT, Phillips JJ, Molinaro AM, Lin Y, Perry A, Haas-Kogan D, Costello JF, Dayal M, Butowski NA, Clarke JL, Prados M, Berger MS, Nelson SJ, Chang SM. Adjuvant temozolomide for low grade gliomas: Molecular and radiographic correlates of treatment response in a phase II clinical trial. Journal of Clinical Oncology. 34: 2002-2002. DOI: 10.1200/Jco.2016.34.15_Suppl.2002 |
0.336 |
|
| 2016 |
Wick MJ, Rundle M, Gamez L, Diaz A, Sommer J, Cogswell P, Hann B, Phillips J, Papadopoulos KP. Abstract 627: Establishment and characterization of a panel of cell-based and patient-derived chordoma tumor models Cancer Research. 76: 627-627. DOI: 10.1158/1538-7445.Am2016-627 |
0.371 |
|
| 2016 |
Maleschlijski S, Elkhaled A, Jalbert L, Olson MP, Chang S, Phillips J, Berger MS, Nelson S. NIMG-58. AUTOMATED APPROACH TO PREDICTING MALIGNANT TRANSFORMATIONS IN RECURRENT LOW-GRADE GLIOMAS USING EX VIVO SPECTROSCOPIC DATA Neuro-Oncology. 18: vi137-vi137. DOI: 10.1093/Neuonc/Now212.569 |
0.303 |
|
| 2016 |
Chen H, Thomas C, Munoz FA, Alexandrescu S, Horbinski C, Olar A, McGuone D, Camelo-Piragua S, Wang L, Pentsova E, Phillips J, Aldape K, Iafrate AJ, Golfinos J, Chi A, et al. MPTH-34. THE PROGNOSTIC VALUE OF POLYSOMY IN OLIGODENDROGLIAL TUMORS Neuro-Oncology. 18: vi113-vi113. DOI: 10.1093/Neuonc/Now212.471 |
0.365 |
|
| 2016 |
Viswanath P, Izquierdo-Garcia JL, Phillips JJ, Pieper RO, Ronen S. Metb-06. Down Regulation Of Phospholipid Metabolism Is A Unique Hallmark Of Mutant Idh1 Glioma Cells Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.420 |
0.313 |
|
| 2016 |
Grossauer S, Koeck K, Murphy N, Phillips J, Wrainwright D, Okada H, Mueller S, James CD, Nicolaides T, Petritsch CK. IMST-20. MAPK PATHWAY BLOCKADE PRIMES BRAFV600E MUTANT GLIOMA FOR IMMUNOTHERAPY Neuro-Oncology. 18: vi90-vi90. DOI: 10.1093/Neuonc/Now212.376 |
0.308 |
|
| 2016 |
Shelton SJ, Johnson BE, Mazor T, Potts MB, McDermott MF, Huang EJ, Lim D, Pieper RO, Berger MS, Phillips JJ, Costello JF, Oldham MC. GENT-15. INTEGRATED MOLECULAR PROFILING OF HUMAN BRAIN TUMORS THROUGH MULTIOMIC ANALYSIS OF SERIAL SECTIONS (MASS) Neuro-Oncology. 18: vi76-vi77. DOI: 10.1093/Neuonc/Now212.321 |
0.334 |
|
| 2016 |
Kline C, Solomon D, Perry A, Bastian B, Joseph N, Phillips J, Tihan T, Yeh I, Van Ziffle J, Grenert J, Bollen A, Mueller S, Banerjee A, Gupta N, Raffel C, et al. TB-02UPFRONT, REAL-TIME TUMOR AND GERMLINE SEQUENCING OF PEDIATRIC BRAIN TUMOR PATIENTS: THE UCSF EXPERIENCE Neuro-Oncology. 18: iii169.2-iii169. DOI: 10.1093/Neuonc/Now084.02 |
0.372 |
|
| 2016 |
Gururangan S, Becher O, Leary S, Onar-Thomas A, Huang J, Phillips J, Stewart CF, Fangusaro J, Lulla R, Baxter P, Pollack I, Boyett J, Fouladi M. EPT-19PHASE I TRIAL OF PALBOCICLIB, A CDK4/6 INHIBITOR IN CHILDREN WITH RETINOBLASTOMA PROTEIN (RB1) + RECURRENT CENTRAL NERVOUS SYSTEM (CNS) TUMORS (PBTC 042) Neuro-Oncology. 18: iii28.1-iii28. DOI: 10.1093/Neuonc/Now069.18 |
0.33 |
|
| 2015 |
Lerner RG, Grossauer S, Kadkhodaei B, Meyers I, Sidorov M, Koeck K, Hashizume R, Ozawa T, Phillips JJ, Berger MS, Nicolaides T, James CD, Petritsch CK. Targeting a Plk1-controlled polarity checkpoint in therapy-resistant glioblastoma-propagating cells. Cancer Research. PMID 26573800 DOI: 10.1158/0008-5472.Can-14-3689 |
0.349 |
|
| 2015 |
Lau D, Hervey-Jumper SL, Chang S, Molinaro AM, McDermott MW, Phillips JJ, Berger MS. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas. Journal of Neurosurgery. 1-10. PMID 26544781 DOI: 10.3171/2015.5.Jns1577 |
0.397 |
|
| 2015 |
Butowski N, Colman H, De Groot JF, Omuro AM, Nayak L, Wen PY, Cloughesy TF, Marimuthu A, Haidar S, Perry A, Huse J, Phillips J, West BL, Nolop KB, Hsu HH, et al. Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study. Neuro-Oncology. PMID 26449250 DOI: 10.1093/Neuonc/Nov245 |
0.358 |
|
| 2015 |
Mazor T, Pankov A, Johnson BE, Hong C, Hamilton EG, Bell RJ, Smirnov IV, Reis GF, Phillips JJ, Barnes MJ, Idbaih A, Alentorn A, Kloezeman JJ, Lamfers ML, Bollen AW, et al. DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors. Cancer Cell. 28: 307-17. PMID 26373278 DOI: 10.1016/J.Ccell.2015.07.012 |
0.408 |
|
| 2015 |
Izquierdo-Garcia JL, Viswanath P, Eriksson P, Cai L, Radoul M, Chaumeil MM, Blough M, Luchman HA, Weiss S, Cairncross JG, Phillips JJ, Pieper RO, Ronen SM. IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism. Cancer Research. PMID 26045167 DOI: 10.1158/0008-5472.Can-15-0840 |
0.347 |
|
| 2015 |
Prados MD, Byron SA, Tran NL, Phillips JJ, Molinaro AM, Ligon KL, Wen PY, Kuhn JG, Mellinghoff IK, de Groot JF, Colman H, Cloughesy TF, Chang SM, Ryken TC, Tembe WD, et al. Toward precision medicine in glioblastoma: the promise and the challenges. Neuro-Oncology. 17: 1051-63. PMID 25934816 DOI: 10.1093/Neuonc/Nov031 |
0.326 |
|
| 2015 |
Reis GF, Pekmezci M, Hansen HM, Rice T, Marshall RE, Molinaro AM, Phillips JJ, Vogel H, Wiencke JK, Wrensch MR, Walsh KM, Perry A. CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas. Journal of Neuropathology and Experimental Neurology. 74: 442-52. PMID 25853694 DOI: 10.1097/Nen.0000000000000188 |
0.38 |
|
| 2015 |
Phillips J, Tihan T, Fuller G. Practical molecular pathology and histopathology of embryonal tumors. Surgical Pathology Clinics. 8: 73-88. PMID 25783823 DOI: 10.1016/J.Path.2014.10.003 |
0.37 |
|
| 2015 |
Safaee M, Fakurnejad S, Bloch O, Clark AJ, Ivan ME, Sun MZ, Oh T, Phillips JJ, Parsa AT. Proportional upregulation of CD97 isoforms in glioblastoma and glioblastoma-derived brain tumor initiating cells. Plos One. 10: e0111532. PMID 25714433 DOI: 10.1371/Journal.Pone.0111532 |
0.38 |
|
| 2015 |
Izquierdo-Garcia JL, Viswanath P, Eriksson P, Chaumeil MM, Pieper RO, Phillips JJ, Ronen SM. Metabolic reprogramming in mutant IDH1 glioma cells. Plos One. 10: e0118781. PMID 25706986 DOI: 10.1371/Journal.Pone.0118781 |
0.366 |
|
| 2015 |
Wade A, Engler JR, Tran VM, Phillips JJ. Measuring sulfatase expression and invasion in glioblastoma. Methods in Molecular Biology (Clifton, N.J.). 1229: 507-16. PMID 25325976 DOI: 10.1007/978-1-4939-1714-3_39 |
0.413 |
|
| 2015 |
Ivan ME, Safaee M, Oh T, Clark AJ, Sun MZ, Kim J, Bloch O, Jahangiri A, Phillips JJ, Aghi MK, Parsa AT. Epidermal growth factor-like module containing mucin-like hormone receptor 2 expression in gliomas. Journal of Neuro-Oncology. 121: 53-61. PMID 25200831 DOI: 10.1007/S11060-014-1606-Z |
0.359 |
|
| 2015 |
Wahl MT, Aicardi J, Haas-Kogan DA, Butowski NA, Clarke JL, Prados M, Phillips JJ, Berger MS, Chang SM. A phase II study of temozolomide in the treatment of adult patients with supratentorial low-grade glioma. Journal of Clinical Oncology. 33: 2022-2022. DOI: 10.1200/Jco.2015.33.15_Suppl.2022 |
0.332 |
|
| 2015 |
Lindberg O, McKinney A, Engler J, Phillips J. Tmod-09Distinct Tumor Phenotypes From Neural Progenitor Cell-Derived Tumors Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov237.09 |
0.409 |
|
| 2015 |
Luks T, McKnight TR, Williams A, Lobo K, Persson A, Phillips J, Molinaro A, Chang S, Nelson S. NIMG-48MR DIFFUSION PROFILES OF NON-ENHANCING LOWER-GRADE GLIOMAS Neuro-Oncology. 17: v164.4-v165. DOI: 10.1093/Neuonc/Nov225.48 |
0.399 |
|
| 2015 |
Shelton S, Johnson B, Mazor T, Potts M, McDermott M, Huang E, Lim D, Pieper R, Berger M, Phillips J, Costello J, Oldham M. MPTH-29CONNECTING MUTANT GENOTYPES TO ABERRANT TRANSCRIPTIONAL SIGNATURES ACROSS SERIAL SECTIONS OF A HUMAN TUMOR Neuro-Oncology. 17: v144.4-v145. DOI: 10.1093/Neuonc/Nov222.29 |
0.43 |
|
| 2015 |
Mazor T, Johnson BE, Grimmer M, Hong C, Hamilton EG, Jones LE, Xavier-Magalhães A, Smirnov IV, Bengtsson H, Olshen AB, Petrecca K, Bollen AW, Berger MS, Taylor BS, Nelson SJ, ... ... Phillips JJ, et al. GENO-25HYPERMUTATION AND MALIGNANT PROGRESSION IN AN EXPANDED COHORT OF TEMOZOLOMIDE-TREATED LOW-GRADE GLIOMA PATIENTS Neuro-Oncology. 17: v97.1-v97. DOI: 10.1093/Neuonc/Nov215.25 |
0.448 |
|
| 2015 |
Viswanath P, Izquierdo-Garcia JL, Eriksson P, Cai L, Radoul M, Chaumeil MM, Blough M, Luchmann HA, Weiss S, Cairncross JG, Phillips JJ, Pieper RO, Ronen SM. Cbio-42Down Regulation Of Pyruvate Dehydrogenase Activity Is Essential For Cell Proliferation In Idh1 Mutant Glioma Cells. Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov209.42 |
0.367 |
|
| 2015 |
Ohba S, Mukherjee J, Johannessen TA, Hirose Y, Chow T, Marshall R, Walsh K, Perry A, Phillips J, Ronen S, Pieper R. CBIO-32MUTANT IDH EXPRESSION DRIVES hTERT REACTIVATION AS PART OF THE CELLULAR TRANSFORMATION PROCESS Neuro-Oncology. 17: v61.3-v61. DOI: 10.1093/Neuonc/Nov209.32 |
0.35 |
|
| 2015 |
McKinney A, Lindberg O, Engler J, Gong H, Shieh J, Phillips J. Cbio-31Mechanisms Of Resistance To Egfr Inhibition Reveal Metabolic Vulnerabilities In Human Gbm Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov209.31 |
0.407 |
|
| 2015 |
Griveau A, Shelton S, Tien A, Seano G, Yuen T, Sabo J, Lau J, Jahangiri A, Huillard E, Phillips J, Persson A, Oldham M, Weiss W, Aghi M, Stiles C, et al. ANGI-04Olig2 REGULATES Wnt7b EXPRESSION AND VASCULATURE CHARACTERISTICS IN GLIOMA Neuro-Oncology. 17: v41.4-v41. DOI: 10.1093/Neuonc/Nov207.04 |
0.388 |
|
| 2015 |
Wahl M, Aicardi J, Molinaro A, Haas-Kogan D, Butowski N, Clarke J, Prados M, Phillips J, Berger M, Chang S. ATCT-32A PHASE II STUDY OF TEMOZOLOMIDE IN THE TREATMENT OF ADULT PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMA Neuro-Oncology. 17: v8.4-v9. DOI: 10.1093/Neuonc/Nov206.32 |
0.33 |
|
| 2015 |
Lau D, Hervey-Jumper S, Chang S, Molinaro A, McDermott M, Phillips J, Berger M. ATCT-21A PROSPECTIVE PHASE II CLINICAL TRIAL OF 5-AMINOLEVULINIC ACID TO CORRELATE INTRAOPERATIVE FLUORESCENCE INTENSITY WITH HISTOLOGIC CELLULARITY Neuro-Oncology. 17: v6.1-v6. DOI: 10.1093/Neuonc/Nov206.21 |
0.393 |
|
| 2015 |
Iikhanizadeh S, Miroshnikova Y, Frantz A, Zhu W, Idilli A, Quigley D, Lakins J, Magnitsky S, Phillips J, James D, Berger M, Arosio D, Sun D, Weaver V, Weiss W, et al. ATPS-63OSMOTIC SWELLING REGULATES TUMOR GROWTH AND DRUG UPTAKE IN HUMAN GLIOBLASTOMA Neuro-Oncology. 17: v32.1-v32. DOI: 10.1093/Neuonc/Nov204.63 |
0.397 |
|
| 2015 |
Venneti S, Santi M, Felicella MM, Yarilin D, Phillips J, Sullivan L, Martinez D, Perry A, Lewis P, Thompson C, Judkins A. HG-07 * DETECTION OF K27M MUTANT PEDIATRIC GLIOBLASTOMAS BY IMMUNOHISTOCHEMISTRY Neuro-Oncology. 17: iii12-iii12. DOI: 10.1093/Neuonc/Nov061.44 |
0.42 |
|
| 2015 |
Lindberg OR, McKinney A, Engler JR, Phillips JJ. Sc-02Modeling Pediatric Gbm Using Neural Stem Cell-Derived Tumors With Divergent Behavior Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov061.144 |
0.416 |
|
| 2014 |
Izquierdo-Garcia JL, Cai LM, Chaumeil MM, Eriksson P, Robinson AE, Pieper RO, Phillips JJ, Ronen SM. Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylase. Plos One. 9: e108289. PMID 25243911 DOI: 10.1371/Journal.Pone.0108289 |
0.355 |
|
| 2014 |
Venneti S, Santi M, Felicella MM, Yarilin D, Phillips JJ, Sullivan LM, Martinez D, Perry A, Lewis PW, Thompson CB, Judkins AR. A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas. Acta Neuropathologica. 128: 743-53. PMID 25200322 DOI: 10.1007/S00401-014-1338-3 |
0.403 |
|
| 2014 |
Chaumeil MM, Larson PE, Woods SM, Cai L, Eriksson P, Robinson AE, Lupo JM, Vigneron DB, Nelson SJ, Pieper RO, Phillips JJ, Ronen SM. Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in glioma. Cancer Research. 74: 4247-57. PMID 24876103 DOI: 10.1093/Neuonc/Nou239.7 |
0.346 |
|
| 2014 |
Spence T, Sin-Chan P, Picard D, Barszczyk M, Hoss K, Lu M, Kim SK, Ra YS, Nakamura H, Fangusaro J, Hwang E, Kiehna E, Toledano H, Wang Y, Shi Q, ... ... Phillips J, et al. CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathologica. 128: 291-303. PMID 24839957 DOI: 10.1007/S00401-014-1291-1 |
0.404 |
|
| 2014 |
Elkhaled A, Jalbert L, Constantin A, Yoshihara HA, Phillips JJ, Molinaro AM, Chang SM, Nelson SJ. Characterization of metabolites in infiltrating gliomas using ex vivo ¹H high-resolution magic angle spinning spectroscopy. Nmr in Biomedicine. 27: 578-93. PMID 24596146 DOI: 10.1002/Nbm.3097 |
0.365 |
|
| 2014 |
Mack SC, Witt H, Piro RM, Gu L, Zuyderduyn S, Stütz AM, Wang X, Gallo M, Garzia L, Zayne K, Zhang X, Ramaswamy V, Jäger N, Jones DT, Sill M, ... ... Phillips J, et al. Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature. 506: 445-50. PMID 24553142 DOI: 10.1038/Nature13108 |
0.326 |
|
| 2014 |
Dahiya S, Emnett RJ, Haydon DH, Leonard JR, Phillips JJ, Perry A, Gutmann DH. BRAF-V600E mutation in pediatric and adult glioblastoma. Neuro-Oncology. 16: 318-9. PMID 24311634 DOI: 10.1093/Neuonc/Not146 |
0.307 |
|
| 2014 |
Mueller S, Hashizume R, Yang X, Kolkowitz I, Olow AK, Phillips J, Smirnov I, Tom MW, Prados MD, James CD, Berger MS, Gupta N, Haas-Kogan DA. Targeting Wee1 for the treatment of pediatric high-grade gliomas. Neuro-Oncology. 16: 352-60. PMID 24305702 DOI: 10.1093/Neuonc/Not220 |
0.394 |
|
| 2014 |
Davies JM, Robinson AE, Cowdrey C, Mummaneni PV, Ducker GS, Shokat KM, Bollen A, Hann B, Phillips JJ. Generation of a patient-derived chordoma xenograft and characterization of the phosphoproteome in a recurrent chordoma. Journal of Neurosurgery. 120: 331-6. PMID 24286145 DOI: 10.3171/2013.10.Jns13598 |
0.305 |
|
| 2014 |
Sun MZ, Oh MC, Ivan ME, Kaur G, Safaee M, Kim JM, Phillips JJ, Auguste KI, Parsa AT. Current management of choroid plexus carcinomas. Neurosurgical Review. 37: 179-92; discussion 1. PMID 24068529 DOI: 10.1007/S10143-013-0499-1 |
0.331 |
|
| 2014 |
Swartling FJ, Bolin S, Phillips JJ, Persson AI. Signals that regulate the oncogenic fate of neural stem cells and progenitors. Experimental Neurology. 260: 56-68. PMID 23376224 DOI: 10.1016/J.Expneurol.2013.01.027 |
0.38 |
|
| 2014 |
Butowski NA, Colman H, De Groot JF, Omuro AMP, Nayak L, Cloughesy TF, Marimuthu A, Perry A, Phillips JJ, West B, Prados M, Nolop KB, Hsu HH, Ligon KL. A phase 2 study of orally administered PLX3397 in patients with recurrent glioblastoma. Journal of Clinical Oncology. 32: 2023-2023. DOI: 10.1200/Jco.2014.32.15_Suppl.2023 |
0.388 |
|
| 2014 |
Banerjee A, Jakacki R, Onar-Thomas A, Wu S, Nicolaides T, Turner D, Richardson S, Young-Poussaint T, Phillips JJ, Prados M, Packer R, Qaddoumi IA, Gururangan S, Goldman S, Pollack I, et al. A phase 1 study of AZD6244 in children with recurrent or refractory low-grade gliomas: A Pediatric Brain Tumor Consortium report. Journal of Clinical Oncology. 32: 10065-10065. DOI: 10.1200/Jco.2014.32.15_Suppl.10065 |
0.309 |
|
| 2014 |
Izquierdo-Garcia J, Eriksson P, Cai L, Chaumeil M, Pieper R, Phillips J, Ronen S. Tm-0713C Mrs Detects Metabolic Flux Adaptation In Idh Mutant Glioma Cells Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou278.7 |
0.318 |
|
| 2014 |
Jalbert L, Phillips J, Molinaro A, Chang S, Nelson S. NI-40 * MR IMAGING AND SPECTROSCOPY PROVIDES INSIGHT INTO MALIGNANT TRANSFORMATION AND IDH-MUTATION STATUS IN DIFFUSE LOW-GRADE GLIOMA Neuro-Oncology. 16: v146-v147. DOI: 10.1093/Neuonc/Nou264.38 |
0.391 |
|
| 2014 |
Nagarajan R, Barajas R, Mazor T, Phillips J, Ma J, Hong C, Johnson B, Dayal M, Cha S, Nakamura J, Berger M, Chang S, Furnari F, Taylor B, Costello J. GE-42 * INTEGRATED RADIOGRAPHIC AND PHYLOGENETIC CASE STUDY OF A PRIMARY AND CONTRALATERAL RECURRENT GLIOMA Neuro-Oncology. 16: v105-v106. DOI: 10.1093/Neuonc/Nou256.41 |
0.436 |
|
| 2014 |
Johnson B, Mazor T, Hong C, Barnes M, Yamamoto S, Ueda H, Tatsuno K, Aihara K, Asthana S, Dayal M, Nelson S, Phillips J, Bollen A, Mukasa A, Saito N, et al. GE-15 * CLONAL EVOLUTION AND INTRATUMORAL HETEROGENEITY OF LOW-GRADE GLIOMA GENOMES Neuro-Oncology. 16: v99-v99. DOI: 10.1093/Neuonc/Nou256.15 |
0.435 |
|
| 2014 |
Mazor T, Pankov A, Johnson BE, Hong C, Bell RJA, Smirnov IV, Reis GF, Phillips JJ, Barnes M, Bollen AW, Taylor BS, Molinaro AM, Olshen AB, Song JS, Berger MS, et al. EG-07 * CELL CYCLE SIGNATURE AND TUMOR PHYLOGENY ARE ENCODED IN THE EVOLUTIONARY DYNAMICS OF DNA METHYLATION IN GLIOMA Neuro-Oncology. 16: v76-v76. DOI: 10.1093/Neuonc/Nou254.7 |
0.446 |
|
| 2014 |
Salinas R, Liu J, Delgado R, Park KY, Price J, Ramos A, Phillips J, Lim D. EG-14 * EPIGENETIC DYSREGULATION OF THE HoxA LOCUS AND OTHER HOMEOBOX GENES DRIVEN BY Ink4a/arf DEFICIENCY AND EGFRviii Neuro-Oncology. 16: v78-v78. DOI: 10.1093/Neuonc/Nou254.14 |
0.45 |
|
| 2014 |
McKinney A, Engler J, Phillips J. Ai-20Mechanisms Of Resistance To Egfr Inhibition Associated With An Invasive Phenotype Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou238.20 |
0.399 |
|
| 2014 |
Costello JF, Mazor T, Pankov A, Johnson BE, Hong C, Bell RJA, Smirnov IV, Reis GF, Phillips JJ, Barnes M, Bollen AW, Taylor BS, Molinaro AM, Olshen AB, Song JS, et al. CLONAL EVOLUTION OF GLIOMAS IS ENCODED IN THE EVOLUTIONARY DYNAMICS OF DNA METHYLATION Neuro-Oncology. 16: iii51-iii52. DOI: 10.1093/Neuonc/Nou209.38 |
0.438 |
|
| 2014 |
Clarke JL, Chang S, Phillips J, Molinaro A, Berger M, Nelson S, Haas-Kogan D. EVEROLIMUS (RAD001) AND THE MTOR PATHWAY IN LOW-GRADE GLIOMAS Neuro-Oncology. 16: iii48-iii48. DOI: 10.1093/Neuonc/Nou209.24 |
0.431 |
|
| 2014 |
Phillips JJ, Wade A, Tran VM, McKinney A. Extracellular Regulators Of Glioblastoma Signaling Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou206.65 |
0.418 |
|
| 2014 |
Nelson SJ, Elkhaled A, Jalbert L, Wen Q, Phillips JJ, Molinaro A, Berger M, Chang SM. EX VIVO METABOLIC SIGNATURES OF GLIOMAS BASED UPON TUMOR GRADE, IMAGING CHARACTERISTICS AND TREATMENT HISTORY Neuro-Oncology. 16: iii12-iii13. DOI: 10.1093/Neuonc/Nou206.44 |
0.374 |
|
| 2014 |
Chang SM, Elkhaled A, Jalbert L, Phillips JJ, Cha S, Molinaro A, Nelson SJ. IMAGING BIOMARKERS OF MALIGNANT PROGRESSION OF DIFFUSE LOW-GRADE GLOMA (LGG) Neuro-Oncology. 16: iii1-iii22. DOI: 10.1093/Neuonc/Nou206.43 |
0.413 |
|
| 2014 |
Ronen SM, Izquierdo-Garcia JL, Chaumeil MM, Cai LM, Phillips JJ, Pieper RO. Metabolic Imaging Biomarkers For Mutant Idh1 Gliomas Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou206.41 |
0.381 |
|
| 2013 |
Chaumeil MM, Larson PE, Yoshihara HA, Danforth OM, Vigneron DB, Nelson SJ, Pieper RO, Phillips JJ, Ronen SM. Non-invasive in vivo assessment of IDH1 mutational status in glioma. Nature Communications. 4: 2429. PMID 24019001 DOI: 10.1038/Ncomms3429 |
0.353 |
|
| 2013 |
Sun MZ, Kim JM, Oh MC, Safaee M, Kaur G, Clark AJ, Bloch O, Ivan ME, Kaur R, Oh T, Fouse SD, Phillips JJ, Berger MS, Parsa AT. Naâº/Kâº-ATPase β2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells. Neuro-Oncology. 15: 1518-31. PMID 23887941 DOI: 10.1093/Neuonc/Not099 |
0.414 |
|
| 2013 |
Abedalthagafi M, Phillips JJ, Kim GE, Mueller S, Haas-Kogen DA, Marshall RE, Croul SE, Santi MR, Cheng J, Zhou S, Sullivan LM, Martinez-Lage M, Judkins AR, Perry A. The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 1425-32. PMID 23765250 DOI: 10.1038/Modpathol.2013.90 |
0.373 |
|
| 2013 |
Kaur G, Kim J, Kaur R, Tan I, Bloch O, Sun MZ, Safaee M, Oh MC, Sughrue M, Phillips J, Parsa AT. G-protein coupled receptor kinase (GRK)-5 regulates proliferation of glioblastoma-derived stem cells. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 20: 1014-8. PMID 23693024 DOI: 10.1016/J.Jocn.2012.10.008 |
0.363 |
|
| 2013 |
Venneti S, Felicella MM, Coyne T, Phillips JJ, Gorovets D, Huse JT, Kofler J, Lu C, Tihan T, Sullivan LM, Santi M, Judkins AR, Perry A, Thompson CB. Histone 3 lysine 9 trimethylation is differentially associated with isocitrate dehydrogenase mutations in oligodendrogliomas and high-grade astrocytomas. Journal of Neuropathology and Experimental Neurology. 72: 298-306. PMID 23481705 DOI: 10.1097/Nen.0B013E3182898113 |
0.404 |
|
| 2013 |
Mukherjee J, Phillips JJ, Zheng S, Wiencke J, Ronen SM, Pieper RO. Pyruvate kinase M2 expression, but not pyruvate kinase activity, is up-regulated in a grade-specific manner in human glioma. Plos One. 8: e57610. PMID 23451252 DOI: 10.1371/Journal.Pone.0057610 |
0.387 |
|
| 2013 |
Phillips JJ, Aranda D, Ellison DW, Judkins AR, Croul SE, Brat DJ, Ligon KL, Horbinski C, Venneti S, Zadeh G, Santi M, Zhou S, Appin CL, Sioletic S, Sullivan LM, et al. PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma. Brain Pathology (Zurich, Switzerland). 23: 565-73. PMID 23438035 DOI: 10.1111/Bpa.12043 |
0.374 |
|
| 2013 |
Wade A, Robinson AE, Engler JR, Petritsch C, James CD, Phillips JJ. Proteoglycans and their roles in brain cancer. The Febs Journal. 280: 2399-417. PMID 23281850 DOI: 10.1111/Febs.12109 |
0.309 |
|
| 2013 |
Joseph NM, Phillips J, Dahiya S, M Felicella M, Tihan T, Brat DJ, Perry A. Diagnostic implications of IDH1-R132H and OLIG2 expression patterns in rare and challenging glioblastoma variants. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 315-26. PMID 23041832 DOI: 10.1038/Modpathol.2012.173 |
0.378 |
|
| 2013 |
Haas-Kogan D, Phillips JJ, Molinaro A, Wahl M, Mueller S, Weiss WA, Lupo JM, Berger MS, Prados MD, Butowski N, Clarke J, Perry A, Nelson SJ, Chang S. Abstract 3520: Imaging parameters and molecular correlates as predictive markers of treatment response to mTOR inhibition in adults with recurrent low-grade gliomas. Cancer Research. 73: 3520-3520. DOI: 10.1158/1538-7445.Am2013-3520 |
0.378 |
|
| 2012 |
Wiencke JK, Accomando WP, Zheng S, Patoka J, Dou X, Phillips JJ, Hsuang G, Christensen BC, Houseman EA, Koestler DC, Bracci P, Wiemels JL, Wrensch M, Nelson HH, Kelsey KT. Epigenetic biomarkers of T-cells in human glioma. Epigenetics : Official Journal of the Dna Methylation Society. 7: 1391-402. PMID 23108258 DOI: 10.4161/Epi.22675 |
0.364 |
|
| 2012 |
Hashizume R, Smirnov I, Liu S, Phillips JJ, Hyer J, McKnight TR, Wendland M, Prados M, Banerjee A, Nicolaides T, Mueller S, James CD, Gupta N. Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment. Journal of Neuro-Oncology. 110: 305-13. PMID 22983601 DOI: 10.1007/S11060-012-0973-6 |
0.443 |
|
| 2012 |
Engler JR, Robinson AE, Smirnov I, Hodgson JG, Berger MS, Gupta N, James CD, Molinaro A, Phillips JJ. Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas. Plos One. 7: e43339. PMID 22937035 DOI: 10.1371/Journal.Pone.0043339 |
0.388 |
|
| 2012 |
Lu KV, Chang JP, Parachoniak CA, Pandika MM, Aghi MK, Meyronet D, Isachenko N, Fouse SD, Phillips JJ, Cheresh DA, Park M, Bergers G. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell. 22: 21-35. PMID 22789536 DOI: 10.1016/J.Ccr.2012.05.037 |
0.355 |
|
| 2012 |
Mueller S, Phillips J, Onar-Thomas A, Romero E, Zheng S, Wiencke JK, McBride SM, Cowdrey C, Prados MD, Weiss WA, Berger MS, Gupta N, Haas-Kogan DA. PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome. Neuro-Oncology. 14: 1146-52. PMID 22753230 DOI: 10.1093/Neuonc/Nos140 |
0.34 |
|
| 2012 |
Barajas RF, Phillips JJ, Parvataneni R, Molinaro A, Essock-Burns E, Bourne G, Parsa AT, Aghi MK, McDermott MW, Berger MS, Cha S, Chang SM, Nelson SJ. Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging. Neuro-Oncology. 14: 942-54. PMID 22711606 DOI: 10.1093/Neuonc/Nos128 |
0.348 |
|
| 2012 |
Phillips JJ. Novel therapeutic targets in the brain tumor microenvironment. Oncotarget. 3: 568-75. PMID 22643827 DOI: 10.18632/Oncotarget.526 |
0.433 |
|
| 2012 |
Swartling FJ, Savov V, Persson AI, Chen J, Hackett CS, Northcott PA, Grimmer MR, Lau J, Chesler L, Perry A, Phillips JJ, Taylor MD, Weiss WA. Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC. Cancer Cell. 21: 601-13. PMID 22624711 DOI: 10.1016/J.Ccr.2012.04.012 |
0.395 |
|
| 2012 |
Huillard E, Hashizume R, Phillips JJ, Griveau A, Ihrie RA, Aoki Y, Nicolaides T, Perry A, Waldman T, McMahon M, Weiss WA, Petritsch C, James CD, Rowitch DH. Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy. Proceedings of the National Academy of Sciences of the United States of America. 109: 8710-5. PMID 22586120 DOI: 10.1073/Pnas.1117255109 |
0.347 |
|
| 2012 |
Phillips JJ, Huillard E, Robinson AE, Ward A, Lum DH, Polley MY, Rosen SD, Rowitch DH, Werb Z. Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma. The Journal of Clinical Investigation. 122: 911-22. PMID 22293178 DOI: 10.1172/Jci58215 |
0.383 |
|
| 2012 |
Elkhaled A, Jalbert LE, Phillips JJ, Yoshihara HA, Parvataneni R, Srinivasan R, Bourne G, Berger MS, Chang SM, Cha S, Nelson SJ. Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas. Science Translational Medicine. 4: 116ra5. PMID 22238333 DOI: 10.1126/Scitranslmed.3002796 |
0.376 |
|
| 2012 |
Goldhoff P, Clarke J, Smirnov I, Berger MS, Prados MD, James CD, Perry A, Phillips JJ. Clinical stratification of glioblastoma based on alterations in retinoblastoma tumor suppressor protein (RB1) and association with the proneural subtype. Journal of Neuropathology and Experimental Neurology. 71: 83-9. PMID 22157621 DOI: 10.1097/Nen.0B013E31823Fe8F1 |
0.421 |
|
| 2012 |
Tihan T, Ersen A, Qaddoumi I, Sughayer MA, Tolunay S, Al-Hussaini M, Phillips J, Gupta N, Goldhoff P, Baneerjee A. Pathologic characteristics of pediatric intracranial pilocytic astrocytomas and their impact on outcome in 3 countries: a multi-institutional study. The American Journal of Surgical Pathology. 36: 43-55. PMID 21989351 DOI: 10.1097/Pas.0B013E3182329480 |
0.348 |
|
| 2012 |
Clarke JL, Molinaro AM, Butowski NA, Chang SM, Phillips JJ, Costa BM, Costello JF, Rabbitt JE, Kivett VA, DeSilva AA, Prados M. A single-institution phase II trial of radiation (RT), temozolomide (TMZ), erlotinib, and bevacizumab for initial treatment of glioblastoma (GBM). Journal of Clinical Oncology. 30: 2026-2026. DOI: 10.1200/Jco.2012.30.15_Suppl.2026 |
0.312 |
|
| 2012 |
Proescholdt MA, Merrill MJ, Stoerr E, Lohmeier A, Brawanski A, Sim H, Hu B, Pineda CA, Yoon S, Viapiano MS, Rajappa P, Cobb WS, Huang Y, Lyden DC, Bromberg J, ... ... Phillips JJ, et al. LAB-ANGIOGENESIS AND INVASION Neuro-Oncology. 14: vi1-vi6. DOI: 10.1093/Neuonc/Nos219 |
0.319 |
|
| 2011 |
Sugiarto S, Persson AI, Munoz EG, Waldhuber M, Lamagna C, Andor N, Hanecker P, Ayers-Ringler J, Phillips J, Siu J, Lim DA, Vandenberg S, Stallcup W, Berger MS, Bergers G, et al. Asymmetry-defective oligodendrocyte progenitors are glioma precursors. Cancer Cell. 20: 328-40. PMID 21907924 DOI: 10.1016/J.Ccr.2011.08.011 |
0.334 |
|
| 2011 |
Park I, Bok R, Ozawa T, Phillips JJ, James CD, Vigneron DB, Ronen SM, Nelson SJ. Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imaging. Journal of Magnetic Resonance Imaging : Jmri. 33: 1284-90. PMID 21590996 DOI: 10.1002/Jmri.22563 |
0.343 |
|
| 2011 |
McKnight TR, Smith KJ, Chu PW, Chiu KS, Cloyd CP, Chang SM, Phillips JJ, Berger MS. Choline metabolism, proliferation, and angiogenesis in nonenhancing grades 2 and 3 astrocytoma. Journal of Magnetic Resonance Imaging : Jmri. 33: 808-16. PMID 21448944 DOI: 10.1002/Jmri.22517 |
0.374 |
|
| 2011 |
Hashizume R, Aoki Y, Liu S, Smirnov I, Phillips JJ, McKnight T, James CD, Gupta N. Abstract 4307: Establishment of a patient-derived diffuse infiltrative pontine glioma primary cell line and animal model: Implications for future investigations and treatment Cancer Research. 71: 4307-4307. DOI: 10.1158/1538-7445.Am2011-4307 |
0.306 |
|
| 2011 |
Swartling FJ, Persson AI, Lau J, Northcott PA, Grimmer MR, Chesler L, Perry A, Phillips JJ, Taylor MD, Weiss WA. Abstract 3451: Interactions between N-myc and Sox9 promote medulloblastoma and determine cell fate decisions in cerebellar neural stem cells Cancer Research. 71: 3451-3451. DOI: 10.1158/1538-7445.Am2011-3451 |
0.382 |
|
| 2011 |
Pavel H, Ajeawung N, Faure R, Poirier D, Kamnasaran D, Ajeawung N, Joshi H, Kamnasaran D, Poirier D, Ajeawung N, Kamnasaran D, Lun X, Zemp F, Sun B, Stechishin O, ... ... Phillips J, ... ... Phillips JJ, et al. PRECLINICAL EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY Neuro-Oncology. 13: iii107-iii120. DOI: 10.1093/Neuonc/Nor158 |
0.31 |
|
| 2010 |
Kane AJ, Sughrue ME, Rutkowski MJ, Phillips JJ, Parsa AT. EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target. Neuroreport. 21: 1018-22. PMID 20827226 DOI: 10.1097/Wnr.0B013E32833F19F2 |
0.346 |
|
| 2010 |
Srinivasan R, Phillips JJ, Vandenberg SR, Polley MY, Bourne G, Au A, Pirzkall A, Cha S, Chang SM, Nelson SJ. Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM. Neuro-Oncology. 12: 1152-61. PMID 20647244 DOI: 10.1093/Neuonc/Noq075 |
0.423 |
|
| 2010 |
Phillips JJ, Misra A, Feuerstein BG, Kunwar S, Tihan T. Pituicytoma: characterization of a unique neoplasm by histology, immunohistochemistry, ultrastructure, and array-based comparative genomic hybridization. Archives of Pathology & Laboratory Medicine. 134: 1063-9. PMID 20586639 DOI: 10.1043/2009-0167-Cr.1 |
0.318 |
|
| 2010 |
Swartling FJ, Grimmer MR, Hackett CS, Northcott PA, Fan QW, Goldenberg DD, Lau J, Masic S, Nguyen K, Yakovenko S, Zhe XN, Gilmer HC, Collins R, Nagaoka M, Phillips JJ, et al. Pleiotropic role for MYCN in medulloblastoma. Genes & Development. 24: 1059-72. PMID 20478998 DOI: 10.1101/Gad.1907510 |
0.432 |
|
| 2010 |
Yoon DJ, Kwan BH, Chao FC, Nicolaides TP, Phillips JJ, Lam GY, Mason AB, Weiss WA, Kamei DT. Intratumoral therapy of glioblastoma multiforme using genetically engineered transferrin for drug delivery. Cancer Research. 70: 4520-7. PMID 20460527 DOI: 10.1158/0008-5472.Can-09-4311 |
0.379 |
|
| 2006 |
Smith JS, Quiñones-Hinojosa A, Phillips JJ, Bollen AW, McDermott MW, Cha S. Limitations of diffusion-weighted imaging in distinguishing between a brain tumor and a central nervous system histoplasmoma. Journal of Neuro-Oncology. 79: 217-8. PMID 16850113 DOI: 10.1007/S11060-005-9007-Y |
0.309 |
|
| Show low-probability matches. |
